EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

How Does Age Affect Outcomes After Left Ventricular Assist Device Implantation: Results from the PCHF-VAD Registry

Sumant P Radhoe iD, Jesse F Veenis, Nina Jakus, Philippe Timmermans, Anne-Catherine Pouleur, Pawel Rubís, Emeline M Van Craenenbroeck, Edvinas Gaizauskas, Eduardo Barge-Caballero, Stefania Paolillo, Sebastian Grundmann, Domenico D'Amario und 16 weitere

ESC Heart Failure · 01.04.2023 · 10 (2) · 884-894

DOI: 10.1002/ehf2.14247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 02.12.2022. Verfasst von Sumant P Radhoe und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Thorax Center, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure, Thrombosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Use of left ventricular assist devices (LVADs) in older patients has increased, and assessing outcomes in older LVAD recipients is important. Therefore, this study aimed to investigate associations between age and outcomes after continuous-flow LVAD (cf-LVAD) implantation. Methods and results Cf-LVAD patients from the multicentre European PCHF-VAD registry were included and categorized into those <50, 50–64, and ≥65 years old. The primary endpoint was all-cause mortality. Among secondary outcomes were heart failure (HF) hospitalizations, right ventricular (RV) failure, haemocompatibility score, bleeding events, non-fatal thromboembolic events, and device-related infections. Of 562 patients, 184 (32.7%) were <50, 305 (54.3%) were aged 50–64, whereas 73 (13.0%) were ≥65 years old. Median follow-up was 1.1 years. Patients in the oldest age group were significantly more often designated as destination therapy (DT) candidates (61%). A 10 year increase in age was associated with a significantly higher risk of mortality (hazard ratio [HR] 1.34, 95% confidence interval [CI] [1.15–1.57]), intracranial bleeding (HR 1.49, 95% CI [1.10–2.02]), and non-intracranial bleeding (HR 1.30, 95% CI [1.09–1.56]), which was confirmed by a higher mean haemocompatibility score (1.37 vs. 0.77, oldest vs. youngest groups, respectively, P = 0.033). Older patients suffered from less device-related infections requiring systemic antibiotics. No age-related differences were observed in HF-related hospitalizations, ventricular arrhythmias, pump thrombosis, non-fatal thromboembolic events, or RV failure.

Conclusions

In the PCHF-VAD registry, higher age was associated with increased risk of mortality, and especially with increased risk of major bleeding, which is particularly relevant for the DT population. The risks of HF hospitalizations, pump thrombosis, ventricular arrhythmia, or RV failure were comparable. Strikingly, older patients had less device-related infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart FailureThrombosisHumansAgedTreatment OutcomeArrhythmias, CardiacRegistries

Stichwörter der Autor:innen

Advanced heart failureAgeDestination therapyLeft ventricular assist devicesSurvival

Autor:innen und Institutionen

  • Department of Cardiology, Thorax Center, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Center Zagreb, Zagreb, Croatia.
  • Department of Cardiology, University Hospital Leuven, Leuven, Belgium.
  • Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc, Brussels, Belgium.
  • Pôle de Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Louvain, Belgium.
  • Department of Cardiac and Vascular Diseases Krakow, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.

ORCID-Profile: Sumant P Radhoe

Zitieren

APA

Radhoe, S. P., Veenis, J. F., Jakus, N., Timmermans, P., Pouleur, A. C., Rubís, P., Van Craenenbroeck, E. M., Gaizauskas, E., Barge-Caballero, E., Paolillo, S., Grundmann, S., D'Amario, D., Braun, O. Ö., Gkouziouta, A., Planinc, I., Samardzic, J., Meyns, B., Droogne, W., Wierzbicki, K., …, & Brugts, J. J. (2023). How Does Age Affect Outcomes After Left Ventricular Assist Device Implantation: Results from the PCHF-VAD Registry. ESC Heart Failure, 10(2), 884-894. https://doi.org/10.1002/ehf2.14247

Vancouver

Radhoe SP, Veenis JF, Jakus N, Timmermans P, Pouleur AC, Rubís P, et al. How Does Age Affect Outcomes After Left Ventricular Assist Device Implantation: Results from the PCHF-VAD Registry. ESC Heart Failure. 2023;10(2):884-894. doi:10.1002/ehf2.14247

BibTeX
@article{Radhoe2023,
  author = {Radhoe, Sumant P and Veenis, Jesse F and Jakus, Nina and Timmermans, Philippe and Pouleur, Anne-Catherine and Rubís, Pawel and Van Craenenbroeck, Emeline M and Gaizauskas, Edvinas and Barge-Caballero, Eduardo and Paolillo, Stefania and Grundmann, Sebastian and D'Amario, Domenico and Braun, Oscar Ö and Gkouziouta, Aggeliki and Planinc, Ivo and Samardzic, Jure and Meyns, Bart and Droogne, Walter and Wierzbicki, Karol and Holcman, Katarzyna and Flammer, Andreas J and Gasparovic, Hrvoje and Biocina, Bojan and Lund, Lars H and Milicic, Davor and Ruschitzka, Frank and Cikes, Maja and Brugts, Jasper J},
  title = {How Does Age Affect Outcomes After Left Ventricular Assist Device Implantation: Results from the PCHF-VAD Registry},
  journal = {ESC Heart Failure},
  year = {2023},
  volume = {10},
  number = {2},
  pages = {884--894},
  doi = {10.1002/ehf2.14247}
}
Kostenlos starten →